Crossmark

Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy

Published Online: 2016-01-16

Published Print: 2016-12

Authors

Rusckowski, Mary

Wang, Yuzhen

Blankenberg, Francis G.

Levashova, Zoia

Backer, Marina V.

Backer, Joseph M. https://orcid.org/0000-0002-2044-4819
Funding

Funding for this research was provided by:

National Cancer Institute (2R44CA141806-02A1)
License Information

Text and Data Mining valid from 2016-01-16

Version of Record valid from 2016-01-16
More Information

Article History

Received: 1 December 2015

Accepted: 11 January 2016

First Online: 16 January 2016

Document is current